GENPF (Genix Pharmaceuticals) Other Stockholders Equity: $0.99 Mil (As of Apr. 2026)


What is Genix Pharmaceuticals Other Stockholders Equity?

Genix Pharmaceuticals GENPF Other Stockholders Equity is $0.99 Mil as of Apr. 2026. The stock has 3 warning signs investors should review.

Genix Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Apr. 2026 was $0.99 Mil.

Genix Pharmaceuticals's quarterly Other Stockholders Equity increased from Oct. 2025 ($0.97 Mil) to Jan. 2026 ($0.99 Mil) and increased from Jan. 2026 ($0.99 Mil) to Apr. 2026 ($0.99 Mil).

Genix Pharmaceuticals's annual Other Stockholders Equity increased from Oct. 2023 ($0.94 Mil) to Oct. 2024 ($0.96 Mil) and increased from Oct. 2024 ($0.96 Mil) to Oct. 2025 ($0.97 Mil).

Genix Pharmaceuticals Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Other Stockholders Equity Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.90 0.94 0.96 0.97

Genix Pharmaceuticals Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.96 0.97 0.99 0.99

Genix Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.99 Mil mean?
Genix Pharmaceuticals (GENPF) has a Other Stockholders Equity of $0.99 Mil as of Apr. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Other Stockholders Equity too high?
Genix Pharmaceuticals' current Other Stockholders Equity is $0.99 Mil.
How does Genix Pharmaceuticals' Other Stockholders Equity compare to ZTS and UTHR?
Genix Pharmaceuticals' Other Stockholders Equity of $0.99 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Other Stockholders Equity is $0.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Other Stockholders Equity of $0.99 Mil. The current Other Stockholders Equity is $0.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Other Stockholders Equity is $0.99 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.